Amid the high incidence of the delta variable AY.4.2 Worldwide, a new study revealed that antibodies after infection with corona are less effective against different variants, and for the study published in the journal Nature MicrobiologyThe research team from Kings College London looked at the antibodies of 38 patients and health care workers who were infected during the first wave of corona, before they were vaccinated.
The researchers found that antibody levels in most people (18/19 patients) 10 months after they were infected, and the authors said that while antibodies from a particular variant of corona were able to generate a strong response to future infections from its variant, they were found to be Less effective when fighting different variants.
Antibodies from survivors and variants
Vaccines designed around a different type may be less effective against other variants
The researchers also found that current vaccines designed around the original alternative to Corona They provide the best protection against all variants and, therefore, should be used in vaccination programmes, said Dr Liane Dupont from the Department of Infectious Diseases, School of Immunology and Microbial Sciences, Kings College London.
WHO: Delta variant AY 4.2 is now present in 42 countries
As of October 25, more than 26,000 cases of have been reported Delta sub AY.4.2 from 42 countries, according to the WHO, which contains three additional mutations and is said to be 10-15# more transmissible than the original delta variant.
The importance of vaccination
A new study published by the US Centers for Disease Control and Prevention (CDC) said:CDC) People who are not vaccinated and have a recent infection are five times more likely to get corona than those who have recently been fully vaccinated and have not had a previous infection.